JXR MEDI MORA SPARKLE
A phase III, multi-center, randomized, placebo-controlled, double-blind study to assess efficacy and safety of crizanlizumab (5 mg/kg) versus placebo, with or without hydroxyurea/hydroxycarbamide therapy, in adolescent and adult Sickle Cell Disease…
- Status
- Accepting Candidates
- Ages
- 12 Years - 100 Years
- Sexes
- All
JXR MEDI CHEH M21-341
This study will evaluate the efficacy and safety of Armour Thyroid treatment compared with synthetic T4 in subjects who have primary hypothyroidism and are currently stabilized (i.e., in-range thyroid-stimulating hormone [TSH]) on synthetic T4…
- Investigator
- Joe M Chehade
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All
JXR MEDI SEER ALA-LHC
The ALA-LHC is a longitudinal, multi-center cohort study that will enroll approximately 4,000 young adults between the ages of 25-35 who do not have severe lung disease. The overarching objective of the ALA-LHC is to establish a national cohort of…
- Investigator
- Vandana K Seeram
- Status
- Accepting Candidates
- Ages
- 25 Years - 35 Years
- Sexes
- All